Douglas Prechtel, | |
801 Ostrum St, Bethlehem, PA 18015-1000 | |
(484) 526-6643 | |
Not Available |
Full Name | Douglas Prechtel |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 21 Years |
Location | 801 Ostrum St, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184671083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | OS013308 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Home Health | Bethlehem, PA | Home health agency |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN's QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
Telehealth use has surged during the pandemic at clinics that serve lower-income Americans, which allowed the clinics to maintain access to care at a time when many other health care organizations saw significant declines in utilization, according to a new RAND Corporation study.
› Verified 7 days ago
Entity Name | St Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN's QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
Telehealth use has surged during the pandemic at clinics that serve lower-income Americans, which allowed the clinics to maintain access to care at a time when many other health care organizations saw significant declines in utilization, according to a new RAND Corporation study.
› Verified 7 days ago
Entity Name | Gslpg, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN's QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
Telehealth use has surged during the pandemic at clinics that serve lower-income Americans, which allowed the clinics to maintain access to care at a time when many other health care organizations saw significant declines in utilization, according to a new RAND Corporation study.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Douglas Prechtel, 920 Church St N, Concord, NC 28025-2927 Ph: () - | Douglas Prechtel, 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-6643 |
News Archive
QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN's QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
Telehealth use has surged during the pandemic at clinics that serve lower-income Americans, which allowed the clinics to maintain access to care at a time when many other health care organizations saw significant declines in utilization, according to a new RAND Corporation study.
› Verified 7 days ago
Marie Eloise Antoine Pena-teotico, M.D.-M.B.A. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Dr. Mark Andrew Scaccia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 148-452-6664 | |
Hamid Mukhtar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2649 Schoenersville Rd Ste 100, Bethlehem, PA 18017 Phone: 484-884-8110 Fax: 610-868-5333 | |
Dr. Komal Bhavin Dumaswala, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, St. Lukes Internal Medicine, Bethlehem, PA 18015 Phone: 484-526-6643 | |
Ayoola Olukunmi Oladejo, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Dr. Nicole Lynn Grube, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 Fax: 484-884-9297 |